Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Avaxia Biologics

Request full access

Avaxia Biologics develops orally-delivered antibody therapeutics using a proprietary antibody platform

Lexington, United StatesFounded 2005Biotech & Life Sciences

About Avaxia Biologics

Avaxia Biologics, now under Circle33, specializes in the development of orally administered, gut-targeted antibody therapeutics. The company focuses on creating gastrointestinal (GI) stable recombinant monoclonal antibodies, which are designed to treat inflammatory conditions with minimal systemic exposure and low immunogenicity. Avaxia's flagship product, AVX 470, a bovine polyclonal milk-derived anti-TNF antibody, has demonstrated promising results in a Phase 1b clinical trial for ulcerative colitis (UC). The company operates in the biopharmaceutical market, targeting both adult and pediatric inflammatory bowel disease (IBD), a market estimated to be worth approximately $9 billion worldwide. Avaxia's business model includes selling or licensing its technology for commercialization, leveraging its strong intellectual property portfolio and significant investment in research and development. The company generates revenue through these business arrangements and aims to address unmet medical needs in the GI therapeutic space.

Source: Dealroom company data

Avaxia Biologics in the Lexington ecosystem

Live from Dealroom

The Avaxia Biologics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Fort Point Angels
  • Maine Angels
  • Beta Fund
  • Golden Seeds

Series B and later1 investor entered at this stage

  • Cherrystone Angels
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Lexington HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Avaxia Biologics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Avaxia Biologics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.